(Q36452689)

14 August 2017

A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase (English)

1 reference

14 August 2017

James E Crowe

5

0 references

Natalie J Thornburg

object named as

Natalie J Thornburg

4

0 references

author name string

Masahiko Hayakawa

1

1 reference

14 August 2017

Narihiro Toda

2

1 reference

14 August 2017

Nancy Carrillo

3

1 reference

14 August 2017

Carlos F Barbas

6

1 reference

14 August 2017

language of work or name

1 reference

10 September 2012

1 reference

14 August 2017

1 reference

14 August 2017

13

1 reference

14 August 2017

15

1 reference

14 August 2017

2191-2195

1 reference

Vaccine design of hemagglutinin glycoprotein against influenza

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Structural basis of influenza virus neutralization

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Potent Inhibition of HIV‐1 Entry with a Chemically Programmed Antibody Aided by an Efficient Organocatalytic Synthesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Influenza hemagglutinin and neuraminidase membrane glycoproteins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Direct Observation of an Enamine Intermediate in Amine Catalysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

An antibody-recruiting small molecule that targets HIV gp120.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Emergence and pandemic potential of swine-origin H1N1 influenza virus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

An efficient chemical approach to bispecific antibodies and antibodies of high valency

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Instant immunity through chemically programmable vaccination and covalent self-assembly

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Beta-lactam-based approach for the chemical programming of aldolase antibody 38C2

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

The war against influenza: discovery and development of sialidase inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Neuraminidase inhibitors for influenza

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Pandemic influenza: is an antiviral response realistic?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Polytriazoles as copper(I)-stabilizing ligands in catalysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Are we ready for pandemic influenza?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Rational design of potent sialidase-based inhibitors of influenza virus replication

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Influenza virus neuraminidase: structure, antibodies, and inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Synthesis of C-4 and C-7 triazole analogs of zanamivir as multivalent sialic acid containing scaffolds

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517015

The annual production cycle for influenza vaccine

28 June 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201200439

Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201200439

Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201200439

Chemically programmed antibodies: endothelin receptor targeting CovX-Bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201200439

Expanding the concept of chemically programmable antibodies to RNA aptamers: chemically programmed biotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201200439

Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201200439

Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201200439

Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201200439

Benzimidazole and related ligands for Cu-catalyzed azide-alkyne cycloaddition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201200439

Analysis and optimization of copper-catalyzed azide-alkyne cycloaddition for bioconjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201200439

Preparation of integrin alpha(v)beta3-targeting Ab 38C2 constructs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201200439

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/22965667

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22965667

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CBIC.201200439

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22965667

1 reference